ACUREX THERAPEUTICS
AcureX Therapeutics is a biotechnology company. The mission of AcureX Therapeutics is to halt neurodegenerative diseases starting with Parkinson’s Disease.
ACUREX THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2019-01-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.acurex.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Google Apps For Business Wix Hosted
Similar Organizations
Agro Epigenetics Corp
Agro Epigenetics Corp is a canadian biotechnology company.
Current Employees Featured
Founder
Investors List
The Silverstein Foundation
The Silverstein Foundation investment in Grant - AcureX Therapeutics
Official Site Inspections
http://www.acurex.com Semrush global rank: 5.84 M Semrush visits lastest month: 1.42 K
- Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
- IP address: 54.176.110.96
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "AcureX Therapeutics"
Leadership | Board of Directors | Collaborators & Advisors | Acurex ...
She is the Co-Founder of Acurex Therapeutics, focused on developing therapies for neurodegenerative diseases. Previously, Galina co-founded and served as Executive Vice …See details»
AcureX Therapeutics - Crunchbase Company Profile & Funding
AcureX Therapeutics is located in San Carlos, California, United States. Who invested in AcureX Therapeutics? AcureX Therapeutics has 3 investors including Michael J. Fox Foundation and …See details»
Acurex Biosciences - LinkedIn
Acurex’s platform and founding intellectual property are based on a Stanford University breakthrough discovery enabling the identification of druggable targets that induce biomarker changes in ...See details»
Acurex Biosciences - Company Profile & Staff Directory - ContactOut
Acurex Biosciences is a pharmaceutical company with a mission to halt major neurodegenerative diseases driven by impaired mitophagy, starting with Parkinson’s disease (PD). A large body …See details»
AcureX Therapeutics Company Profile 2024: Valuation, Funding ...
AcureX Therapeutics General Information Description. Operator of a pharmaceutical company intended to halt major neurodegenerative diseases. The company specializes in supporting …See details»
AcureX Therapeutics Corporation - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AcureX Therapeutics Corporation of San Carlos, CA. Get the latest business insights from Dun & …See details»
AcureX Therapeutics - Contacts, Employees, Board Members
AcureX Therapeutics has 2 current employee profiles, including Co-Founder, Chairman of the Board Lev J. Leytes. Lev J. Leytes Co-Founder, Chairman of the Board William D. Shrader CEOSee details»
The Silverstein Foundation for Parkinson’s with GBA Announces …
The AcureX team is led by veteran scientists with a proven track record in CNS drug development and serial life sciences entrepreneurs. ... The Silverstein Foundation is a 501(c)(3) non-profit …See details»
AcureX Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
AcureX Therapeutics - Funding, Financials, Valuation & Investors
Apr 27, 2022 AcureX Therapeutics has raised 3 rounds. Their latest funding was raised on Apr 27, 2022 from a Grant round. AcureX Therapeutics is funded by 3 investors. Michael J. Fox …See details»
AcureX Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View AcureX Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
AcureX - MitoWorld
Acurex Biosciences is a pharmaceutical company with a mission to halt major neurodegenerative diseases driven by impaired mitophagy, starting with Parkinson’s disease (PD). A large body …See details»
AcureX Therapeutics - Overview, News & Similar companies
May 30, 2023 AcureX Therapeutics Receives Grant Funding from The Michael J. Fox Foundation For Parkinson’s Research SAN CARLOS, Calif.--(BUSINESS WIRE)--AcureX …See details»
AcureX Therapeutics Receives Grant Funding from The Michael J.
Apr 27, 2022 AcureX’s novel approach and founding intellectual property are based on recent discoveries made by the company’s inventor and co-founder, Xinnan Wang MD, Ph.D. AcureX …See details»
Parkinson’s Disease | Miro1 Biomarker | Mitophagy Discovery …
Acurex’s drug discovery approach uses the phenotypic screening of Miro1 status to pinpoint specific signaling pathways driving mitophagy defects. Acurex’s M3D platform has identified …See details»
The Silverstein Foundation for Parkinson’s with GBA
Aug 31, 2021 AcureX has discovered proprietary targets and drugs that reactivate mitophagy in PD patients by stopping improper signaling to the mitochondrial protein Miro1. ... non-profit …See details»
Acurex Corporation - Crunchbase Company Profile & Funding
Organization. Acurex Corporation . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Acurex Corporation is a manufacturer of products …See details»
Acurex : Uses, Dosage, Side Effects, FAQ - MedicinesFAQ
Sep 19, 2023 Acurex. Acurex is a synthetic purine neucleotide analogue, which acts against human herpes viruses. The enzyme thymidine kinase (TK)encoded by HSV, VZV and EBV …See details»